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Abstract
The aim of the study was to assess the prevalence, the distribution and the impact on disability of grey matter (GM)
pathology in early multiple sclerosis. Eighty-eight patients with a clinically isolated syndrome with a high risk developing
multiple sclerosis were included in the study. Forty-four healthy controls constituted the normative population. An
optimized statistical mapping analysis was performed to compare each subject’s GM Magnetization Transfer Ratio (MTR)
imaging maps with those of the whole group of controls. The statistical threshold of significant GM MTR decrease was
determined as the maximum p value (p,0.05 FDR) for which no significant cluster survived when comparing each control
to the whole control population. Using this threshold, 51% of patients showed GM abnormalities compared to controls.
Locally, 37% of patients presented abnormalities inside the limbic cortex, 34% in the temporal cortex, 32% in the deep grey
matter, 30% in the cerebellum, 30% in the frontal cortex, 26% in the occipital cortex and 19% in the parietal cortex. Stepwise
regression analysis evidenced significant association (p=0.002) between EDSS and both GM pathology (p=0.028) and T2
white matter lesions load (p=0.019). In the present study, we evidenced that individual analysis of GM MTR map allowed
demonstrating that GM pathology is highly heterogeneous across patients at the early stage of MS and partly underlies
irreversible disability.
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Introduction
Pathological studies have clearly demonstrated that multiple
sclerosis (MS) is an inflammatory disease of the central nervous
system (CNS) characterized by macroscopic inflammatory lesions
of white matter (WM) and grey matter (GM) associated with a
diffuse microscopic inflammatory process of the CNS [1].
Extension of MS related pathology outside the well-known
macroscopic lesions of the WM may explain the low relationship
between disability progression and macroscopic WM lesions
accrual [2]. In particular, the existence of GM pathology is now
recognized as a pathological feature of MS [3]. In vivo, several
MR studies have evidenced GM pathology in patients with
different phenotypes of MS using several methods like magneti-
zation transfer ratio (MTR) imaging [4,5,6,7,8,9,10,11], diffusion
weighted imaging [12,13] or measures of atrophy [14]. Although
the large majority of these studies have explored patients suffering
from MS for several years, some recent studies using MTR or
voxel based morphometry imaging have demonstrated that GM
pathology occurs from the onset of the disease [4,7,14,15].
Unfortunately, these techniques have not been optimized to give
sensitive individual assessments of GM pathology according to
their inability to clearly separate pathological from normal values
at the individual level.
Development of method enable to quantify the extent of GM
pathology at the individual level is now required for a potential
application to the clinical practice. Recently, double inversion
recovery (DIR) technique has provided for the first time in MS an
individual map of the intra-cortical lesions (ICLs) [16]. DIR
appears sensitive to evidence focal inflammatory ICLs in more
than half of the MS population and in about one third of the
patients at the first stage of the disease [17]. However, the ability of
DIR to visualize the overall GM pathology is still suboptimal.
Indeed, compared to histopathological data, DIR imaging is
poorly sensitive to detect all the intracortical lesions [16,18]. In
addition, this technique does not explore the GM pathology
located outside the ICLs and does not provide any quantification
of the GM destructuration [17]. In contrast, MTR imaging
provides a quantitative assessment of GM pathology located inside
the macroscopic as well as the microscopic lesions of the GM.
In the present study, we performed a statistical analysis at the
individual level of MTR maps to assess the prevalence, the
distribution and the impact on disability of GM pathology in early
multiple sclerosis.
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Subjects
Eighty-eight patients presenting with a CIS and 44 healthy
controlsubjects were included in this study.Alltheparticipants gave
their written informed consent to participating in this study, which
wasapproved bythelocalEthicsCommittee (CPP Sud Me ´diterrane ´
I). Patients were recruited at the Department of Neurology
(University Hospital of Marseille), based on the following criteria:
1) age between 16 and 45; 2) occurrence of the first presumed
inflammatory demyelinating event in the central nervous system
(CSF) during the last twelve months, involving either the optic
nerve, the spinal cord, the brainstem or a brain hemisphere; 3) no
previous history of neurological symptom; 4) no possible alternative
diagnosis; 5) a minimum delay since the corticosteroid infusion of
two months; 6) $1 lesion in each of $2 characteristic locations of
the CNS (periventricular, juxtacortical, posterior fossa, spinal cord)
or 1 lesion in one characteristic location combined with oligoclonal
bands in the CSF. The last criteria meant that only CIS patients
with a high risk developing MS were included.
Patients underwent a clinical examination during the first
neurological episode. Another neurological examination was
performed on the day of MRI performed at least two months
after the clinical episode. All the patients’ disability levels were
rated using the expanded disability status scale (EDSS) by the same
neurologist on the day of MRI [19].
MRI exploration
Patients and controls were imaged with a 1.5 Tesla commercially
available unit (Magnetom Vision Plus; Siemens, Erlangen, Ger-
many). The MR imaging protocol included localizer scout imaging,
transverse fast spin-echo proton density-weighted and T2- weighted
sequences (2600/15/85 ms [TR/TE1/TE2], 44 contiguous sec-
tions, 3-mm section thickness, 90u flip angle, 240-mm FOV,
2566256 matrix), and transverse proton density-weighted spoiled
gradient-echo sequences (500/4.7 ms [TR/TE], 44 contiguous
sections, 3-mm section thickness, 30u flip angle, 240-mm FOV,
2566256 matrix) performed without and with magnetization
transfer (MT) saturation (1.5-kHz off-water resonance, 500u).
Image processing
Segmentation processing could be disrupted by the presence of
WM injury (focal demyelinating lesions). To prevent this pitfall, T2
lesions were first delineated onto the T2-weighted images by
means of MRIcro program to obtain a T2-lesion mask. Mmt
images were coregistered on T2-weighted images and the mean
value of the WM signal outside lesions on Mmt images was
transferred in areas where the T2 lesions were delineated. Then,
‘‘corrected’’ Mmt images without lesions were created to provide
GM and WM masks not disrupted by the presence of WM injury.
MTR maps were calculated on a voxel-by-voxel basis according to
the following equation: MTR (%) = ((M0 -M mt)/M0)*100 where
M0 and Mmt were the images obtained without and with MT
saturation pulse, respectively. Then, we performed segmentation
of MTR maps using the GM and WM masks obtained previously.
Finally, GM MTR maps obtained were normalised into the MNI
space using the T2 anatomical template provided by the SPM5
program and smoothed using a 12 mm Gaussian filter.
We used a similar images processing method for healthy
controls except for the steps associated to the lesions.
Statistical mapping analysis
The statistical threshold was defined as the maximum p value
enabling to show no significant cluster when comparing any
individual control with the whole population of controls (two-
sample t-test, SPM5). This conservative criterion allows minimiz-
ing the false positive cluster potentially observed in patients.
Then, we performed the comparison between GM MTR maps
of each patient and GM MTR maps of the 44 controls using the
statistical threshold previously obtained. We obtained individual
statistical maps of differences observed between each patient and
control group. Then, we determined for each patient the extent of
total GM injury defined as the ratio between the volume of GM
injury and the volume of total GM. We also quantified the extent
of local GM injury for the different brain sub-regions. The sub-
regions were delineated on the basis of a computerized atlas (Pick-
atlas, SPM5) and included the frontal cortex, the parietal cortex,
the temporal cortex, the occipital cortex, the limbic cortex, the
deep GM and the cerebellum.
Stepwise regression model was used to evaluate the potential
impact of T2 lesion load and GM MTR on disability (EDSS).
Sensitivity of individual MTR statistical mapping analysis
To assess the sensitivity of the method, we built artificial
abnormal MTR brain maps using data from 6 randomly selected
healthy controls from which MTR percent units were decreased
uniformly by 1 to 15%. This was done by substracting 0.01 to 0.15
from GM voxels of each GM MTR map (imcalc function of SPM).
Statistical mapping analyses of these modified MTR maps were
then assessed and quantified using the predefined threshold.
Relative volumes of GM abnormalities according to the
percentage of global MTR degradation were plotted for the six
subjects to determine the sensitivity of the method.
Assessment of the variability of regional GM MTR values
in controls
In order to evaluate the local GM MTR variance in the control
population, we computed a variance map of GM MTR of the
whole control population. Regional mean values of the variance
have been reported for each of the same brain sub-regions used to
quantify regional WM and GM lesions.
Results
Clinical and conventional MRI findings
Patients’ demographic, clinical characteristics are reported in
Table 1. In the CIS population, fifty four out of the eighty eight
patients (61%) fulfilled the McDonald 2010 criteria for MS [20].
In patients, the mean total T2 lesions volume was 4.6 cm
3
(SD=8), the mean number of T2 lesions was 15.7 (SD=13) and
the mean number of gadolinium enhancing lesions was 2.3
(SD=4.3).
Mean age of the controls was 25.8 years (range: 18 to 50 years).
Statistical threshold
Individualanalysescontrastingeachcontrolwiththewholegroup
of controls were performed. The maximum p value enabling to
show no significant cluster when comparing any individual control
with the whole population of controls was p,0.05 (FDR corrected;
k=10). Using this threshold the minimum T-value obtained for a
significant cluster in a patient was 2.9.
Sensitivity of individual MTR statistical mapping analysis
At the same threshold used to detect local GM abnormalities in
patients, (p,0.05, FDR corrected; k=10), we observed significant
clusters in the modified MTR maps of controls starting at 3% of
artificial decrease in MTR for 3 out of the 6 controls. At 4% of
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PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24969MTR decrease all controls showed GM abnormalities (see
Figure 1). This approach allowed demonstrating that patients
showing GM MTR abnormalities at the selected threshold
(p,0.05, FDR corrected; k=10) showed a minimum regional
MTR decreased of 3%.
Variability of regional GM MTR value in controls
The mean values of the variance of GM MTR in controls was
2.4% (SD=1.7%) in the frontal cortex, 3.2% (SD=1.5%) in the
parietal cortex, 2 % (SD=1.7%) in the limbic cortex, 2.9%
(SD=1.6%) in the occipital cortex, 2.5% (1.6%) in the temporal
cortex, 1.5 % (1.7%) in the deep GM and 1.2% (SD=1.4%) in the
cerebellum.
Patterns of individual GM MTR decrease in patients
Using the predefined threshold (p,0.05, FDR corrected;
k=10), forty-five out of the eighty-eight patients (51%) showed
significant regional GM MTR decrease compared to controls.
Examples of individual GM MTR maps obtained in five patients
have been displayed in Figure 2.
Among all patients, 37% presented abnormalities inside the
limbic cortex, 34% in the temporal cortex, 32% in the deep GM,
30% in the cerebellum, 30% in the frontal cortex, 26% in the
occipital cortex and 19% in the parietal cortex (Figure 3). The
distribution of patients according to the relative volume of affected
GM within global and regional GM tissue (limbic cortex, temporal
cortex, deep GM, cerebellum, frontal cortex, occipital cortex and
parietal cortex) has been assessed (Figure 4). In the majority of
the patients showing significant regional GM MTR decrease, the
relative extent of regional GM injury not exceeded 25% of the
volume of the respective region (Figure 4).
Correlation between the extent of GM MTR decrease and
conventional MRI findings in patients
The extent of GM MTR abnormalities was significantly
correlated with the global T2 lesion load (Spearman rank
correlation, p=0.0006) and with the total number of T2 lesions
(Spearman rank correlation, p=0.0047). There is a trend between
the number of gadolinium enhancing lesions and the extent of GM
MTR abnormalities (Spearman rank correlation, p=0.06).
Figure 1. Sensitivity of individual MTR statistical mapping analysis. MTR maps of 6 controls were decreased uniformly in MTR by 1 to 15%.
Statistical mapping analyses of these modified MTR maps were then assessed and quantified using the predefined threshold showing presence of
clusters for all subjects for a 4% decrease in MTR.
doi:10.1371/journal.pone.0024969.g001
Table 1. Demographic and clinical characteristics of patients.
Gender (F/M)
Age (years) (mean,
range)
EDSS (median,mean,
range)
Time to the clinical
onset(month)
(mean, range)
T2 Lesion load (cm
3)
(mean, standard
deviation) Location of symptom
ON SC B H
Patients n=88 70/18 29 (16–45) 0 – 0.6 (0–2) 4.9 (2–12) 4.6 8 21 34 24 9
ON: Optic Nerve, SC: Spinal Cord, B: Brainstem, H: Hemisphere.
doi:10.1371/journal.pone.0024969.t001
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extent of GM MTR abnormalities in the limbic cortex (Spearman
rank correlation, p=0.02). T2 lesions load in the deep white
matter was correlated with the extent of GM MTR abnormalities
in the deep GM (Spearman rank correlation, p=0.02). T2 lesions
load in the parietal region was correlated with the extent of GM
MTR abnormalities in the parietal cortex (Spearman rank
correlation, p=0.02). T2 lesions load in the frontal region was
not correlated with the extent of GM MTR abnormalities in the
frontal cortex (Spearman rank correlation, p=0.18). T2 lesions
load in the occipital region was not correlated with the extent of
GM MTR abnormalities in the occipital cortex (Spearman rank
correlation, p=0.07). T2 lesions load in the cerebellum was not
correlated with the extent of GM MTR abnormalities in the
cerebellar cortex (Spearman rank correlation, p=0.33).
Correlation between the extent of GM MTR decrease,
conventional MRI findings and clinical characteristics in
patients
Stepwise regression analysis evidenced significant association
(p=0.002, R
2=0.135) of EDSS with both grey matter pathology
(p=0.028) and T2 white matter lesions load (p=0.019).
The extent of regional GM MTR decrease was not influenced
by the type of the first clinical symptom (optic neuritic, myelitis,
brainstem or hemispheric symptoms) : cerebellum (ANOVA,
p=0.33), deep GM (ANOVA, p=0.83), frontal cortex (ANOVA,
p=0.75), limbic cortex (ANOVA, p=0.65), occipital cortex
(ANOVA, p=0.47), parietal cortex (ANOVA, p=0.25) and the
temporal cortex (ANOVA, p=0.65).
Discussion
In the present study, an individual quantification of GM
pathology has been applied in a large group of patients at the onset
of MS and provides for the first time the prevalence, the
distribution and the impact on disability of GM pathology in
early multiple sclerosis.
Assessment of GM pathology at the individual level
Recently, quantitative MRI methods have highlighted the
existence of GM pathology in patients suffering from MS [21].
However, these methods applied at the group level, have not been
designed to quantify the extent of GM pathology at the individual
level preventing any potential application for the clinical practice.
In contrast, individual GM MTR mapping quantifies the GM
Figure 2. Statistical mapping of MTR abnormalities in five CIS
patients (A–E) showing various extent of GM injury (range 2–
73%).
doi:10.1371/journal.pone.0024969.g002
Figure 3. Regional distribution of GM injury among the whole
group of CIS patients (n=88). Values represent the proportion of
patients showing GM injury within each sub-region.
doi:10.1371/journal.pone.0024969.g003
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GM MTR decrease (minimum 3%) at the individual level.
Using this method, we demonstrated the existence of GM injury
in about half of patients at the earliest stage of the disease. Using
DIR imaging, Calabrese et al evidenced the existence of GM
lesions one third of CIS patients [17]. The apparent lower
sensitivity of the DIR technique to provide the overall GM
pathology may be related to its lower sensitivity to detect GM
injury outside the macroscopic GM lesions [17]. In contrast, MTR
provides a more global reflect of GM pathology demonstrating
abnormalities inside the macroscopic as well as the microscopic
lesions of the GM while it can not separate these two components.
Therefore, combination of these two techniques, DIR and
individual MTR GM maps analysis, may better reflect the real
extent of GM pathology occurring in MS.
Prevalence and pattern of GM injury at the onset of MS
The present study clearly evidenced that GM injury is common
from the onset of MS and may involved all the GM regions of the
brain. Few previous studies have assessed the distribution of GM
pathology at this stage of the disease [8,14,23,24]. They have used
group analysis and only reflected the collocation of GM injury in
the population of patients but not the distribution of GM
pathology for each subject. They evidenced that the more frequent
mutual locations of GM injury were the deep GM structures and
the limbic system. In contrast to these group analyses, the present
method, using an individual approach, provides the common
pattern of GM injury but also its variability across patients. Using
this method, we demonstrated that GM pathology is highly
heterogeneous across patients. Indeed, only half of patients show
GM abnormalities and among them, the volume of tissue injury is
highly variable. In addition, we evidenced that GM pathology may
occur in all brain regions with a lesser frequency in the parietal
and occipital cortices.
Different mechanisms may contribute to GM pathology
underlying MTR decrease. First, the existence of ICLs has been
clearly demonstrated by histopathological and MRI studies [3,25].
Secondly, axonal impairments resulting from WM lesions may
induce distal GM lesions secondary to Wallerian degeneration or
anterograde transynaptic damage in some regions particularly
connected [26,27,28,29]. The correlation found between the
extent of GM MTR abnormalities and the T2 lesion load supports
this hypothesis. Finally, a neurodegenerative process characterized
by iron deposition may contribute to GM pathology particularly in
the deep GM [30,31]. However, a post-mortem MRI study using
high field MRI performed in MS patients has evidenced that
MTR value in GM lesions was significantly associated with the
degree of demyelination and not with neuronal density. MTR
imaging may be more sensitive to the inflammatory demyelinating
lesions of the cortex compared to the neuronal pathology
secondary to distant WM injury [32].
Relationship between individual extent of GM injury and
disability
MTR imaging has already been used to demonstrate the
existence of correlations between GM injury and irreversible
disability in CIS patients [4,6,7,8,9,10,33,34]. These previous
studies used extracted MTR values from GM masks and tested
correlations with clinical parameters among the global populations
of patients. These MTR values were affected both by physiological
Figure 4. Proportion of affected GM regions in each brain regions in CIS patients. (rvGM injury: relative volume of GM injury).
doi:10.1371/journal.pone.0024969.g004
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pathology at the individual level using a validated voxel based
statistical threshold determined in a control population, provides,
similarly to the depiction of GM lesions using DIR, a quantitative
parameter reflecting individual GM pathology. We suggest that
this parameter could be a relevant surrogate marker of disease
burden.
The impact of early GM pathology on irreversible disability
may partly explain the clinico-radiological paradox observed with
conventional MRI [2]. Indeed, as demonstrated in the present
study, both WM lesions and GM injury contribute to disability.
Although significant, the correlations found between tissue injury
and EDSS remain modest as evidenced by Calabrese et al [17].
Several factors could explain the weakness of this association.
Firstly, CIS patients showed either no or limited disability
consistent with their short disease duration (the mean time from
the first clinical episode was 5 months). Secondly, EDSS scale is
particularly sensitive to spinal cord pathology that is often not
explored. Finally, compensatory processes known to occur from
the very first stage of the disease onwards may often mask the
clinical impact of early GM pathology [35].
Conclusion
In the present study, we evidenced that individual analysis of
GM MTR map allowed demonstrating that GM pathology is
highly heterogeneous across patients at the early stage of MS and
partly underlies irreversible disability.
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